Focus topics

Hungary wants to use Chinese Vaccine as strategic Advantage

Hungary’s planned Covid-19 vaccine production plant will also be equipped to manufacture Chinese Corona vaccines, according to media reports. This was announced by Hungary’s Foreign Minister Péter Szijjártó on Monday after a meeting with his Chinese counterpart Wang Yi, Reuters reported citing Hungary’s state news agency MIT. According to the report, the agreement represents a “great strategic advantage” for Hungary, Szijjártó said. Hungary would become the first EU state to produce Chinese vaccines. It remained open when production of the Chinese vaccine could begin in Hungary. Sinopharm’s product does not yet have European Medicines Agency (EMA) approval for the EU. Hungary had decided to use the vaccine with an emergency approval.

Continue reading now

Get 30 days of free access to the Decision Brief to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now


    Quarantine time halved
    Chip shortage continues to weigh on automakers
    G7: China should increase pressure on Russia
    Chinese competitors drive innovation